Abstract
Hereditary cystatin C amyloid angiopathy (HCCAA) is an autosomal dominant disorder in which a cysteine proteinase inhibitor, cystatin C, is deposited as amyloid fibrils in the cerebral arteries of patients and leads to massive brain haemorrhage and death in young adults. A full length cystatin C cDNA probe revealed a mutation in the codon for leucine at position 68 which abolishes an Alu I restriction site in the cystatin C gene of HCCAA patients. The Alu I marker has been used to show that this mutation is transmitted only in affected members of all eight families investigated, and that the mutated cystatin C gene causes HCCAA.
| Original language | English |
|---|---|
| Pages (from-to) | 603-604 |
| Journal | The Lancet |
| Volume | 332 |
| Issue number | 8611 |
| DOIs | |
| Publication status | Published - 1988 |
Subject classification (UKÄ)
- Pharmacology and Toxicology
- Medicinal Chemistry
Fingerprint
Dive into the research topics of 'Mutation in cystatin C gene causes hereditary brain haemorrhage'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver